首页 > 市场调查报告书 > 医疗设备

医学影像诊断

市场调查报告书

商品编码

1593445

临床试验影像市场规模、份额、成长分析、按服务/软体、按模式、按治疗领域、按最终用户、按地区 - 行业预测，2024-2031 年

Clinical Trial Imaging Market Size, Share, Growth Analysis, By Service and Software, By Modality, By Therapeutic Area, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月14日 | 出版商:

SkyQuest | 英文 194 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年临床试验影像的全球市场规模为12.2亿美元，从2023年的13.2亿美元成长到2031年的24.2亿美元，预计在预测期间（2024-2031年）将以复合年增长率成长。 %。

生物技术和製药行业预计将强劲成长，这主要是由于旨在为各种疾病创造新药的研发投资激增。这种成长与医疗影像领域的显着併购趋势相辅相成，旨在增强医疗设备製造并整合先进成像技术以改善临床测试。儘管医疗影像产业充满活力，但在医疗影像公司大量资本配置的推动下，该产业呈现出稳定的势头。技术进步彻底改变了临床试验影像资料的收集、分析和呈现。特别是，影像分析软体已成为临床研究中的重要工具，透过增强的资料管理方法提供一致性、准确性、扩充性和法规遵循等优势。此外，对电脑技术的更多依赖和增强的计算能力预计将进一步提高临床试验中的影像处理能力。定量成像生物标记联盟（QIBA）通讯协定的建立引入了标准化的资料收集方法，确保临床试验中采用的方法产生真实且可比较的资料。因此，成像技术不断发展，使生物技术和製药产业能够在面对持续的医疗挑战时实现持续成长和创新。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

ICON plc
Medpace
Clario
IXICO plc
Resonance Health Ltd.
Radiant Sage
WCG Clinical
Medical Metrics, Inc.
Prism Clinical Imaging
Boston Imaging Core Lab
Voiant
Calyx
Biospective Inc.
Micron, Inc.
Imaging Endpoints
Perspectum
Competence Network Life Sciences（Pharmtrace）
Median Technologies
Image Core Lab
Image Analysis Group（IAG）

简介目录

Product Code: SQMIG35H2309

Global Clinical Trial Imaging Market size was valued at USD 1.22 billion in 2022 and is poised to grow from USD 1.32 billion in 2023 to USD 2.42 billion by 2031, growing at a CAGR of 7.82% during the forecast period (2024-2031).

The biotechnology and pharmaceutical sectors are poised for robust growth, primarily driven by escalating investments in research and development aimed at creating new drugs for a variety of diseases. This growth is complemented by a noteworthy trend of mergers and acquisitions within the medical imaging domain, which seek to integrate advanced imaging technologies to enhance the manufacturing of medical devices and improve clinical investigations. Despite the dynamic nature of the medical imaging landscape, these industries are seeing steady momentum, propelled by significant capital allocation toward medical imaging firms. Technological advancements have revolutionized the collection, analysis, and presentation of clinical trial imaging data. Notably, image analysis software has emerged as a pivotal tool in clinical research, offering benefits such as increased consistency, accuracy, scalability, and regulatory compliance through enhanced data management methods. Additionally, the growing reliance on computer technology and augmented computing power is expected to further enrich imaging capabilities in clinical trials. The establishment of the Quantitative Imaging Biomarker Alliance (QIBA) protocol has introduced standardized techniques for data collection, ensuring that methodologies employed in clinical trials yield realistic and comparable data. As a result, imaging techniques continue to evolve, positioning the biotechnology and pharmaceutical industries for sustained growth and innovation in the face of ongoing medical challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Trial Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Trial Imaging Market Segmental Analysis

Global Clinical Trial Imaging Market is segmented by Service and Software, Modality, Therapeutic Area, End User, and Region. Based on Service and Software, the market is segmented into Services (Operational Imaging Services, Read Analysis Services, System And Technical Support Services, Trial Design And Consulting Services), Software. Based on Modality, the market is segmented into Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-Ray, Others. Based on Therapeutic Area, the market is segmented into Oncology, Infectious Diseases, Neurology, Cardiovascular System Disorders, Endocrinology, Immunological Disorders, Others. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Contract Research Organizations, Academic And Government Research Institutes, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Clinical Trial Imaging Market

The Global Clinical Trial Imaging market is significantly propelled by rising investments in research and development (R&D) activities within the pharmaceutical and biotechnology sectors. As the complexity of drug development escalates, the demand for precise imaging technologies becomes paramount to effectively monitor treatment outcomes and disease progression during clinical trials. Advanced imaging modalities such as MRI, PET, and CT scans provide essential data that enhances the understanding of a therapy's safety and efficacy, which is critical for regulatory approvals. This growing reliance on sophisticated imaging techniques not only supports the validation of new treatments but also drives innovation and competitiveness in the market.

Restraints in the Global Clinical Trial Imaging Market

The Global Clinical Trial Imaging market faces a significant restraint due to the high costs associated with advanced imaging technologies, such as MRI, PET, and CT scans. These elevated prices can substantially inflate the overall expenses of clinical trials, posing a particular challenge for smaller pharmaceutical companies and research institutions that may lack the financial resources to incorporate these sophisticated imaging modalities. Furthermore, the need for specialized technicians and radiologists further exacerbates the financial burden, often leading to a preference for more conventional imaging methods. This financial strain limits the capacity of many organizations to leverage advanced imaging, potentially stunting innovation and slowing down the progress of clinical research.

Market Trends of the Global Clinical Trial Imaging Market

The Global Clinical Trial Imaging market is experiencing a significant trend towards integrating Artificial Intelligence (AI) and machine learning technologies into imaging systems. This innovation enhances the precision and efficiency of image analysis, significantly minimizing human error and accelerating result turnaround times. AI-driven tools are automating complex imaging processes, which not only streamlines the clinical diagnostic workflow but also makes advanced imaging techniques more accessible and cost-effective. As healthcare stakeholders increasingly recognize the benefits of AI in improving clinical trial outcomes, the demand for these cutting-edge imaging solutions is poised for continued growth, shaping the future of clinical research.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Ecosystem of the Market
Patent Analysis
Pricing Analysis
Trade Analysis
Value Chain Analysis
Supply Chain Analysis
Customer & Buying Criteria Analysis
Case Study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Clinical Trial Imaging Market by Service and Software

Market Overview
Services
- Operational Imaging Services
- Read Analysis Services
- System & Technical Support Services
- Trial Design & Consulting Services
Software

Clinical Trial Imaging Market by Modality

Market Overview
Computed Tomography
Magnetic Resonance Imaging
Ultrasound
Positron Emission Tomography
X-Ray
Others

Clinical Trial Imaging Market by Therapeutic Area

Market Overview
Oncology
Infectious Diseases
Neurology
Cardiovascular System Disorders
Endocrinology
Immunological Disorders
Others

Clinical Trial Imaging Market by End User

Market Overview
Pharmaceutical & Biotechnology Companies
Medical Device Manufacturers
Contract Research Organizations
Academic And Government Research Institutes
Others

Clinical Trial Imaging Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

ICON plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medpace
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clario
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IXICO plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Resonance Health Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Radiant Sage
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WCG Clinical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medical Metrics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prism Clinical Imaging
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Imaging Core Lab
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Voiant
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Calyx
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biospective Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micron, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Imaging Endpoints
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perspectum
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Competence Network Life Sciences (Pharmtrace)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Median Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Image Core Lab
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Image Analysis Group (IAG)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments